MedPath
HSA Approval

ABILIFY ASIMTUFII PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 960MG/3.2ML

SIN17222P

ABILIFY ASIMTUFII PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 960MG/3.2ML

ABILIFY ASIMTUFII PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 960MG/3.2ML

April 22, 2025

LUNDBECK SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLUNDBECK SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SUSPENSION, EXTENDED RELEASE

INTRAMUSCULAR

Medical Information

N05AX12

Manufacturer Information

LUNDBECK SINGAPORE PTE. LTD.

Otsuka Pharmaceutical Co., Ltd.

Active Ingredients

Aripiprazole Monohydrate eqv Aripiprazole

960mg /3.2ml

Aripiprazole

Documents

Package Inserts

Abilify Asimtufii_PI.pdf

Approved: April 22, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.